Article

Therapeutic efficacy of CT-P59 against P.1 variant of SARS-CoV-2

2021-07-09

Abstract excerpt

P.1. or gamma variant also known as the Brazil variant, is one of the variants of concern (VOC) which appears to have high transmissibility and mortality. To explore the potency of the CT-P59 monoclonal antibody against P.1 variant, we tried to conduct binding affinity, in vitro neutralization, and in vivo animal tests. In in vitro assays revealed that CT-P59 is able to neutralize P.1 variant in spite of reduct...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d926da72-1921-5810-bdf6-b9f7d6e690c7
DOI: 10.1101/2021.07.08.451696

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Therapeutic efficacy of CT-P59 against P.1 variant of SARS-CoV-2DOI 10.1101/2021.07.08.451696Read

Therapeutic effect of CT-P59 against SARS-CoV-2 South African variantSemantic proximity Read

SARS-CoV-2 B.1.351 (beta) variant shows enhanced infectivity in K18-hACE2 transgenic mice and expanded tropism to wildtype mice compared to B.1 variantSemantic proximity Read

The <i>in vitro</i> and <i>in vivo</i> potency of CT-P59 against Delta and its associated variants of SARS-CoV-2Semantic proximity Read

B.1.1.7 and B.1.351 variants are highly virulent in K18-ACE2 transgenic mice and show different pathogenic patterns from early SARS-CoV-2 strainsSemantic proximity Read

SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strainsSemantic proximity Read

Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission routeSemantic proximity Read

Efficacy, Pharmacokinetic and Toxicity Profiles of a Broadly SARS-CoV2 Neutralizing AntibodySemantic proximity Read

Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.Semantic proximity Read

Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype MiceSemantic proximity Read

Comparison of 10 emerging SARS-CoV-2 Variants: infectivity, animal tropism, and antibody neutralizationSemantic proximity Read

CVnCoV protects human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2Semantic proximity Read

Characterization of Three Variants of SARS-CoV-2 <i>in vivo</i> Shows Host-Dependent Pathogenicity in HamstersSemantic proximity Read